Comparison of culture-competent virus shedding duration of SARS-CoV-2 Omicron variant in regard to vaccination status: A prospective cohort study
- PMID: 37003909
- PMCID: PMC10040344
- DOI: 10.1016/j.vaccine.2023.03.044
Comparison of culture-competent virus shedding duration of SARS-CoV-2 Omicron variant in regard to vaccination status: A prospective cohort study
Abstract
Previous studies have shown that fully vaccinated patients with SARS-CoV-2 Delta variants has shorter viable viral shedding period compared to unvaccinated or partially vaccinated patients. However, data about effects of vaccination against the viable viral shedding period in patients with SARS-CoV-2 Omicron variants were limited. We compared the viable viral shedding period of SARS-CoV-2 omicron variant regard to vaccination status. Saliva samples were obtained daily from patients with SARS-CoV-2 Omicron variant, and genomic assessments and virus culture was performed to those samples. We found no difference in viable viral shedding period between fully vaccinated and not or partially vaccinated, nor between 1st boostered vs non-boostered patients with SARS-CoV-2 Omicron variant.
Keywords: Infection dynamics; SARS-CoV-2; Virus shedding.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures

Similar articles
-
Comparison of secondary attack rate and viable virus shedding between patients with SARS-CoV-2 Delta and Omicron variants: A prospective cohort study.J Med Virol. 2023 Jan;95(1):e28369. doi: 10.1002/jmv.28369. J Med Virol. 2023. PMID: 36458559 Free PMC article.
-
Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.JAMA Netw Open. 2022 May 2;5(5):e2213606. doi: 10.1001/jamanetworkopen.2022.13606. JAMA Netw Open. 2022. PMID: 35608859 Free PMC article.
-
A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.medRxiv [Preprint]. 2022 Jan 28:2022.01.26.22269927. doi: 10.1101/2022.01.26.22269927. medRxiv. 2022. Update in: EBioMedicine. 2022 May;79:104008. doi: 10.1016/j.ebiom.2022.104008. PMID: 35118480 Free PMC article. Updated. Preprint.
-
Duration of viable virus shedding and polymerase chain reaction positivity of the SARS-CoV-2 Omicron variant in the upper respiratory tract: a systematic review and meta-analysis.Int J Infect Dis. 2023 Apr;129:228-235. doi: 10.1016/j.ijid.2023.02.011. Epub 2023 Feb 18. Int J Infect Dis. 2023. PMID: 36804640 Free PMC article.
-
SARS-CoV-2 viral load and shedding kinetics.Nat Rev Microbiol. 2023 Mar;21(3):147-161. doi: 10.1038/s41579-022-00822-w. Epub 2022 Dec 2. Nat Rev Microbiol. 2023. PMID: 36460930 Free PMC article. Review.
Cited by
-
Risk period for transmission of SARS-CoV-2 and seasonal influenza: a rapid review.Infect Control Hosp Epidemiol. 2025 Feb 24;46(3):1-9. doi: 10.1017/ice.2025.11. Online ahead of print. Infect Control Hosp Epidemiol. 2025. PMID: 39989317 Free PMC article. Review.
-
Virologic Outcomes with Molnupiravir in Non-hospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT Trial.Infect Dis Ther. 2023 Dec;12(12):2725-2743. doi: 10.1007/s40121-023-00891-1. Epub 2023 Nov 23. Infect Dis Ther. 2023. PMID: 37995070 Free PMC article.
-
Investigation of SARS-CoV-2 Infection among Companion Animals in Households with Confirmed Human COVID-19 Cases.Pathogens. 2024 Jun 1;13(6):466. doi: 10.3390/pathogens13060466. Pathogens. 2024. PMID: 38921764 Free PMC article.
References
-
- Chagla Z. The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose. Ann Intern Med. 2021;174(2):JC15. - PubMed
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous